Search

everythinglearnresearchcommunity

for

Search:↓

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Laser treatment for hair loss works equally well on different skin types, but more research is needed for very dark skin.

The document concludes that current treatments for androgenic alopecia are not fully effective, but new therapies like botulinum toxin and PRP show promise, and future gene therapy could be beneficial.

Men with androgenetic alopecia may have higher cardiovascular risk due to elevated serum endocan levels.

Detailed history and physical examination are crucial for diagnosing hair loss.

Combining PRP with minoxidil and finasteride is the most effective treatment for male hair loss.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

The document concludes that careful planning and consideration of male brow anatomy are essential for successful facial rejuvenation with cosmetic surgery.

AB+ blood group is more common in alopecia areata patients.

Finasteride may increase stroke risk in people with clotting tendencies.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Minoxidil is more effective than cetirizine for treating male hair loss.

Serum IMA levels don't help diagnose AGA but may indicate its severity.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Men with male pattern baldness have higher uric acid levels, which can decrease with finasteride treatment.

Scalp threading with PDO threads is an effective treatment for male crown baldness.

Combining microneedling with light therapy increased hair density by 26% in men.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Zinc is crucial for growth and health in rats.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Finasteride helped treat a 28-year-old's facial skin condition.